missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Thomsen-Friedenreich Antigen Antibody (SPM320), Novus Biologicals™
Mouse Monoclonal Antibody
Marke: Novus Biologicals NBP2-45282-0.1MG
459.00 CHF gültig bis 2025-12-16
BESTER Aktionspreis! Benutzen Sie den Promotions-Code "24090" um Ihren Promotions-Preis zu erhalten.
Dieser Artikel kann nicht zurückgegeben werden.
Rückgaberichtlinie anzeigen
Beschreibung
Ensure accurate, reproducible results in Immunohistochemistry (Paraffin), Immunofluorescence
Thomsen-Friedenreich Antigen Monoclonal specifically detects Thomsen-Friedenreich Antigen in Human, Mouse, Rat samples. It is validated for Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin, Immunofluorescence.
Spezifikation
| Thomsen-Friedenreich Antigen | |
| Monoclonal | |
| 0.2 mg/mL | |
| Immunohistochemistry-Paraffin 0.5 - 1.0 ug/ml, Immunofluorescence 0.5 - 1.0 ug/ml | |
| Mouse | |
| Protein A or G purified | |
| RUO | |
| Recognizes a disaccharide epitope, Gal1-3GalNAc, of Thomsen-Friedenreich (TF) antigen. It is specific for both anomeric forms of the disaccharide (TF and TF, including related structures on the glycolipid) and shows no cross-reactivity with sialylated glycophorin. The Thomsen-Friedenreich antigen acts as an oncofetal antigen, with low expression in normal adult tissues but increasing to fetal levels of expression in hyperplasia or malignancy. It is considered as a pan-carcinoma marker. This MAb is capable to agglutinate desialylated red blood cells. During metastasis, the ability of malignant cells to form multicellular aggregates via homotypic or heterotypic aggregation and their adhesion to the endothelium are critical. The tumor-associated carbohydrate Thomsen-Friedenreich antigen (Gal-GalNAc) is involved in tumor cell adhesion and tissue invasion. It also causes an immune response, and overexpression of the antigen causes cancer cells to be more sensitive to natural killer cell lysis. The Thomsen-Friedenreich antigen is suppressed in normal healthy cells and represents one of the few chemically well-defined antigens associated with tumor malignancy. The presence of the Thomsen-Friedenreich antigen on the surface of cancer cells may result from a divergence from the normal pathway for O-linked glycosylation in these cells, most likely caused by inappropriate localization of the enzymes involved in synthesis of the disaccharide. | |
| Store at 4C. | |
| IgM κ |
| Immunohistochemistry (Paraffin), Immunofluorescence | |
| SPM320 | |
| Unconjugated | |
| 10mM PBS and 0.05% BSA with 0.05% Sodium Azide | |
| Neuraminidase-treated human red blood cells | |
| 0.1 mg | |
| Primary | |
| Human, Mouse, Rat | |
| Purified |
Berichtigung von Produktinhalten
Bitte geben Sie uns Ihr Feedback zu den Produktinhalten, indem Sie das folgende Formular ausfüllen.
Name des Produkts
For Research Use Only
Haben Sie Verbesserungsvorschläge?Übermitteln Sie eine inhaltliche Korrektur